Antibodies specific for native PrPSc
    2.
    发明授权
    Antibodies specific for native PrPSc 失效
    针对天然PrPSc特异的抗体

    公开(公告)号:US07052675B2

    公开(公告)日:2006-05-30

    申请号:US11027139

    申请日:2004-12-29

    摘要: Antibodies are disclosed which specifically bind to native PrPSc in situ. Preferred antibodies bind only to the native PrPSc of a particular species e.g., human, cow, sheep, pig, etc. Particularly preferred antibodies bind specifically to a particular isoform of human PrPSc. Preferred antibodies of the invention are (1) produced by phage display methodology, (2) bind specifically to native PrPSc, (3) neutralizes the infectivity of prions, (4) bind to PrPSc in situ and (5) bind 50% or more of PrPSc in a liquid flowable sample. Antibodies of the invention can be bound to a substrate and used to assay a sample (which has any PrPc denatured via proteinase K) for the presence of PrPSc of a specific species which PrPSc is associated with disease. Antibodies which specifically bind to human PrPSc can be labeled and injected carrying out an in vivo diagnostic test to determine if the human is infected with prions associated with disease. The antibodies are preferably produced using phage display technology wherein the genetic material in the phage expressing the antibody is obtained from a mammal with an ablated endogenous PrP protein gene and an endogenous chimeric PrP gene which mammal had been inoculated with PrPSc to induce antibody production.

    摘要翻译: 公开了原位特异性结合天然PrP Sc的抗体。 优选的抗体仅结合特定种类例如人,牛,绵羊,猪等的天然PrP Sc。特别优选的抗体特异性结合人PrP < SUP>。 本发明优选的抗体是(1)通过噬菌体展示法产生,(2)特异性结合天然PrP ,(3)中和朊病毒感染性,(4)结合PrP < Sc(5)在液体可流动的样品中结合50%以上的PrP Sc 。 本发明的抗体可以与底物结合并用于测定样品(其通过蛋白酶K变性的任何PrP c),以获得特异性的PrP PrP Sc 与疾病相关的物种。 可以标记并注射与人PrP标准物质特异性结合的抗体进行体内诊断测试,以确定人是否感染与疾病相关的朊病毒。 优选使用噬菌体展示技术产生抗体,其中表达抗体的噬菌体中的遗传物质是从具有消融的内源性PrP蛋白基因的哺乳动物和内源性嵌合PrP基因获得的,哺乳动物已用PrP < SUP>以诱导抗体产生。

    Antibodies specific for native PrPsc
    3.
    发明授权
    Antibodies specific for native PrPsc 失效
    特异于天然PrPsc的抗体

    公开(公告)号:US06858397B2

    公开(公告)日:2005-02-22

    申请号:US10435602

    申请日:2003-05-09

    摘要: Antibodies are disclosed which specifically bind to native PrPSc in situ. Preferred antibodies bind only to the native PrPSc of a particular species e.g., human, cow, sheep, pig, etc. Particularly preferred antibodies bind specifically to a particular isoform of human PrPSc. Preferred antibodies of the invention are (1) produced by phage display methodology, (2) bind specifically to native PrPSc, (3) neutralizes the infectivity of prions, (4) bind to PrPSc in situ and (5) bind 50% or more of PrPSc in a liquid flowable sample. Antibodies of the invention can be bound to a substrate and used to assay a sample (which has any PrPc denatured via proteinase K) for the presence of PrPSc of a specific species which PrPSc is associated with disease. Antibodies which specifically bind to human PrPSc can be labeled and injected carrying out an in vivo diagnostic test to determine if the human is infected with prions associated with disease. The antibodies are preferably produced using phage display technology wherein the genetic material in the phage expressing the antibody is obtained from a mammal with an ablated endogenous PrP protein gene and an endogenous chimeric PrP gene which mammal had been inoculated with PrPSc to induce antibody production.

    摘要翻译: 公开了与原位PrP 特异性结合的抗体。 优选的抗体仅与特定物种例如人,牛,绵羊,猪等的天然PrP 。 本发明的抗体可以与底物结合并用于测定样品(其通过蛋白酶K变性的任何PrPc)存在PrP Sc与PrP Sc相关的特定物种的PrP 。 可以对与人PrP 特异性结合的抗体进行标记和注射进行体内诊断测试,以确定人是否感染与疾病相关的朊病毒。 优选使用噬菌体展示技术产生抗体,其中表达抗体的噬菌体中的遗传物质是从具有消融的内源性PrP蛋白基因的哺乳动物和内源性嵌合PrP基因获得的,哺乳动物用PrP 接种以诱导抗体 生产。

    Antibodies specific for native PrPSc

    公开(公告)号:US06562341B2

    公开(公告)日:2003-05-13

    申请号:US09943906

    申请日:2001-08-30

    IPC分类号: A61K39395

    摘要: Antibodies are disclosed which specifically bind to native PrPSc in situ. Preferred antibodies bind only to the native PrPSc of a particular species e.g., human, cow, sheep, pig, etc. Particularly preferred antibodies bind specifically to a particular isoform of human PrPSc. Preferred antibodies of the invention are (1) produced by phage display methodology, (2) bind specifically to native PrPSc, (3) neutralizes the infectivity of prions, (4) bind to PrPSc in situ and (5) bind 50% or more of PrPSc in a liquid flowable sample. Antibodies of the invention can be bound to a substrate and used to assay a sample (which has any PrPc denatured via proteinase K) for the presence of PrPSc of a specific species which PrPSc is associated with disease. Antibodies which specifically bind to human PrPSc can be labeled and injected carrying out an in vivo diagnostic test to determine if the human is infected with prions associated with disease. The antibodies are preferably produced using phage display technology wherein the genetic material in the phage expressing the antibody is obtained from a mammal with an ablated endogenous PrP protein gene and an endogenous chimeric PrP gene which mammal had been inoculated with PrPSc to induce antibody production.

    Antibodies specific for native PrPSc
    7.
    发明授权
    Antibodies specific for native PrPSc 失效
    针对天然PrPSc特异的抗体

    公开(公告)号:US06372214B1

    公开(公告)日:2002-04-16

    申请号:US09550374

    申请日:2000-04-13

    IPC分类号: A61K39395

    摘要: Antibodies are disclosed which specifically bind to native PrPSc in situ. Preferred antibodies bind only to the native PrPSc of a particular species e.g., human, cow, sheep, pig, etc. Particularly preferred antibodies bind specifically to a particular isoform of human PrPSc. Preferred antibodies of the invention are (1) produced by phage display methodology, (2) bind specifically to native PrPSc, (3) neutralizes the infectivity of prions, (4) bind to PrPSc in situ and (5) bind 50% or more of PrPSc in a liquid flowable sample. Antibodies of the invention can be bound to a substrate and used to assay a sample (which has any PrPSc denatured via proteinase K) for the presence of PrPSc of a specific species which PrPSc is associated with disease. Antibodies which specifically bind to human PrPSc can be labeled and injected carrying out an in vivo diagnostic test to determine if the human is infected with prions associated with disease. The antibodies are preferably produced using phage display technology wherein the genetic material in the phage expressing the antibody is obtained from a mammal with an ablated endogenous PrP protein gene and an endogenous chimeric PrP gene which mammal had been inoculated with PrPSc to induce antibody production.

    摘要翻译: 公开了与原位PrPSc特异性结合的抗体。 优选的抗体仅结合特定物种例如人,牛,绵羊,猪等的天然PrPSc。特别优选的抗体特异性结合人PrPSc的特异性同种型。 本发明优选的抗体是(1)通过噬菌体展示法产生,(2)特异性结合天然PrPSc,(3)中和朊病毒感染性,(4)原位结合PrPSc,(5)结合50%以上 的PrPSc在液体可流动的样品中。 本发明的抗体可以与底物结合并用于测定PrPSc与疾病相关的特定物种的PrPSc的存在的样品(其通过蛋白酶K变性的任何PrPSc)。 可以对与PrPSc特异性结合的抗体进行标记和注射进行体内诊断测试,以确定人是否感染了与疾病相关的朊病毒。 优选使用噬菌体展示技术制备抗体,其中表达抗体的噬菌体中的遗传物质是从具有消融的内源性PrP蛋白基因的哺乳动物和内源性嵌合PrP基因获得的,哺乳动物已用PrPSc接种以诱导抗体产生。

    Antibodies specific for native PrPSc
    8.
    发明授权
    Antibodies specific for native PrPSc 失效
    针对天然PrPSc特异的抗体

    公开(公告)号:US06290954B1

    公开(公告)日:2001-09-18

    申请号:US09036579

    申请日:1998-03-06

    IPC分类号: A61K39395

    摘要: Antibodies are disclosed which specifically bind to native PrPSc in situ. Preferred antibodies bind only to the native PrPSc of a particular species e.g., human, cow, sheep, pig, etc. Particularly preferred antibodies bind specifically to a particular isoform of human PrPSc. Preferred antibodies of the invention are (1) produced by phage display methodology, (2) bind specifically to native PrPSc, (3) neutralizes the infectivity of prions, (4) bind to PrPSc in situ and (5) bind 50% or more of PrPSc in a liquid flowable sample. Antibodies of the invention can be bound to a substrate and used to assay a sample (which has any PrPc denatured via proteinase K) for the presence of PrPSc of a specific species which PrPSc is associated with disease. Antibodies which specifically bind to human PrPSc can be labeled and injected carrying out an in vivo diagnostic test to determine if the human is infected with prions associated with disease. The antibodies are preferably produced using phage display technology wherein the genetic material in the phage expressing the antibody is obtained from a mammal with an ablated endogenous PrP protein gene and an endogenous chimeric PrP gene which mammal had been inoculated with PrPSc to induce antibody production.

    摘要翻译: 公开了与原位PrPSc特异性结合的抗体。 优选的抗体仅结合特定物种例如人,牛,绵羊,猪等的天然PrPSc。特别优选的抗体特异性结合人PrPSc的特异性同种型。 本发明优选的抗体是(1)通过噬菌体展示法产生,(2)特异性结合天然PrPSc,(3)中和朊病毒感染性,(4)原位结合PrPSc,(5)结合50%以上 的PrPSc在液体可流动的样品中。 本发明的抗体可以结合于底物并用于测定PrPSc与PrPSc与疾病相关的特定物种的PrPSc的存在的样品(其具有通过蛋白酶K变性的任何PrPc)。 可以对与PrPSc特异性结合的抗体进行标记和注射进行体内诊断测试,以确定人是否感染了与疾病相关的朊病毒。 优选使用噬菌体展示技术制备抗体,其中表达抗体的噬菌体中的遗传物质是从具有消融的内源性PrP蛋白基因的哺乳动物和内源性嵌合PrP基因获得的,哺乳动物已用PrPSc接种以诱导抗体产生。

    Antibodies specific for native PrP.sup.Sc

    公开(公告)号:US5846533A

    公开(公告)日:1998-12-08

    申请号:US713939

    申请日:1996-09-13

    摘要: Antibodies are disclosed which specifically bind to native PrP.sup.Sc in situ. Preferred antibodies bind only to the native PrP.sup.Sc of a particular species e.g., human, cow, sheep, pig, etc. Particularly preferred antibodies bind specifically to a particular isoform of human PrP.sup.Sc. Preferred antibodies of the invention are (1) produced by phage display methodology, (2) bind specifically to native PrP.sup.Sc, (3) neutralizes the infectivity of prions, (4) bind to PrP.sup.Sc in situ and (5) bind 50% or more of PrP.sup.Sc in a liquid flowable sample. Antibodies of the invention can be bound to a substrate and used to assay a sample (which has any PrP.sup.c denatured via proteinase K) for the presence of PrP.sup.Sc of a specific species which PrP.sup.Sc is associated with disease. Antibodies which specifically bind to human PrP.sup.Sc can be labeled and injected carrying out an in vivo diagnostic test to determine if the human is infected with prions associated with disease. The antibodies are preferably produced using phage display technology wherein the genetic material in the phage expressing the antibody is obtained from a mammal with an ablated endogenous PrP protein gene and an endogenous chimeric PrP gene which mammal had been inoculated with PrP.sup.Sc to induce antibody production.